USA - NASDAQ:ACHV - US0044685008 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to ACHV. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-21 | HC Wainwright & Co. | Initiate | Buy |
| 2024-11-14 | Rodman & Renshaw | Initiate | Buy |
| 2024-09-27 | Raymond James | Initiate | Strong Buy |
| 2024-08-15 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-05-13 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-04-17 | JonesTrading | Initiate | Buy |
| 2024-04-01 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-03-05 | Lake Street | Maintains | Buy -> Buy |
| 2023-12-12 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-05-31 | Lake Street | Maintains | Buy -> Buy |
| 2023-03-17 | Oppenheimer | Reiterate | Outperform |
| 2022-11-16 | Maxim Group | Maintains | Buy |
| 2021-10-04 | Alliance Global Partners | Initiate | Buy |
| 2021-06-23 | Oppenheimer | Initiate | Outperform |
13 analysts have analysed ACHV and the average price target is 15.64 USD. This implies a price increase of 212.8% is expected in the next year compared to the current price of 5.
The consensus rating for ACHIEVE LIFE SCIENCES INC (ACHV) is 83.0769 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering ACHIEVE LIFE SCIENCES INC (ACHV) is 13.